Biotech · Public company · Mountain View, CA, US
Unicycive Therapeutics, Inc.
Ticker UNCY · SEC CIK 0001766140
Track this companyFree. Adds Unicycive Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials10 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline1
- Oxylanthanum CarbonatePhase 2 · Chronic Kidney Disease Requiring Chronic DialysisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Study to Assess the Tolerability of Oxylanthanum Carbonate in Patients With Chronic Kidney Disease on DialysisPHASE2 · COMPLETED · started Dec 15, 2023ClinicalTrials.gov NCT06218290 · fetched Nov 12, 2026
SEC filings12
- 8-K · CURRENT REPORTSEC EDGAR · filed Sep 29, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Sep 28, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Aug 12, 2026 · fetched Nov 12, 2026
- 10-Q · QUARTERLY REPORTSEC EDGAR · filed Aug 12, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Jul 2, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Jun 22, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Jun 5, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 10-Q · QUARTERLY REPORTSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Apr 6, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Mar 30, 2026 · fetched Nov 12, 2026
- 10-K · ANNUAL REPORTSEC EDGAR · filed Mar 30, 2026 · fetched Nov 12, 2026